Stock Events

Stock Events

Fate Therapeutics (FATE) Q1 2026 Earnings

Feb 26Confirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.38

-0.35

-0.31

-0.27

Details

Expected EPS

-0.27044

Actual EPS

-0.27

Surprise EPS

0

Surprise Percent

+0.16%

Description

⁨Fate Therapeutics⁩ (⁦FATE⁩) has reported earnings of ⁦-0.27⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.